Public market insider buying at Trulieve Cannabis (C:TRUL)

Kimberly Rivers, CEO, Director and 10% Holder, acquired 29,000 Subordinate Voting Shares on a direct ownership basis at a price of US$35.936 on June 15th, 2021. This represents a $1,270,172 investment into the company's shares and an account share holdings change of 59.3%.

Trulieve Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Trulieve Cannabis Corp is a Canada-based medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to dispensaries throughout the State of Florida, as well as to patients via home delivery. It also operates in California, Massachusetts, Connecticut, Pennsylvania and West Virginia. The Company offers a range of products, such as flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. It operates cultivation and processing facility in McKeesport, Pennsylvania. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.